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 ConA successfully disperses MWCNTs and gives to them biorecognition 
properties 
 ConA maintains the recognition properties after the drastic dispersing 
conditions 
 GCE/MWCNTs-ConA is a versatile platform to immobilize 
glycobiomolecules 
 HRP and GOx were attached to GCE/MWCNTs-ConA as proof-of-concept 
 GCE/MWCNT-ConA/HRP-GOx allowed the highly sensitive/selective 
quantification of glucose 
 GCE/MWCNT-ConA/HRP-GOx was successfully used for detecting of 
glucose in complex matrices 
 GCE/MWCNT-ConA/HRP-GOx was successfully used to quantify glucose 
in human serum 
 
ABSTRACT 
We propose an innovative nanoarchitecture for the development of 
electrochemical biosensors based on the non-covalent functionalization of multi-













the site-specific supramolecular binding of glycobiomolecules. As proof-of-
concept, we propose the use of two glycoenzymes, glucose oxidase (GOx) and 
horseradish peroxidase (HRP), for building mono- and bienzymatic glucose 
biosensors. The selected conditions for the preparation of the dispersion were 
1.5 mg MWCNTs in 1.0 mL of 2.0 mg mL-1 ConA sonicated for 5.0 min with 
sonicator probe. The monoenzymatic glucose biosensor was prepared by casting 
GCE with the MWCNTs-ConA dispersion (GCE/MWCNTs-ConA) followed by the 
interaction with GOx (GCE/MWCNTs-ConA/GOx), while the bienzymatic one was 
obtained by interaction of GCE/MWCNTs-ConA with GOx + HRP 
(GCE/MWCNTs-ConA/GOx-HRP). The best analytical performance was 
obtained with the bienzymatic biosensor from the amperometric response at -
0.050 V in the presence of 1.0 x 10-4 M hydroquinone. The sensitivity was (2.22 
± 0.03) μA mM-1 (which was 5.2 times higher than the one obtained with the 
monoenzymatic biosensor) and a detection limit of 0.31 μM. The reproducibility 
was 5.4 % and the biosensor was challenged with human blood serum showing 
an excellent correlation with the values reported by the laboratory.  
 
Keywords: Multi-walled carbon nanotubes functionalization; Concanavalin 
A; Glucose electrochemical biosensor; Bienzymatic biosensor; Site-
specific supramolecular binding. 
 
1. INTRODUCTION 
The search for novel bioanalytical platforms able to conjugate an efficient 
immobilization of biomolecules with an improved electroanalytical performance in 













advanced electrochemical biosensors [1,2]. In this context, carbon nanotubes 
(CNTs) have proven to be an excellent material for the development of innovative 
electrochemical biosensors due to their unique electronic, physical and chemical 
properties [3,4]. However, one of the major problems of using CNTs for the 
preparation of electrochemical (bio)sensors is their strong tendency to form 
agglomerates due to strong van der Waals and π-π interactions [5]. In this regard, 
the non-covalent functionalization of CNTs has received considerable attention 
to minimize these interactions and improve their compatibility with the solvent 
without disturbing their π-conjugated structure [6–9]. Moreover, the rational 
selection of the functionalizing agent represents a very promising strategy to 
prepare tailor-made design of CNTs with specific properties [10]. 
The oriented and site-specific immobilization of enzymes is essential for 
the rational design of biosensors, avoiding difficulties related to the random 
immobilization of enzymes that would produce substantial loss of activity due to 
structural deconformation and shielding of the active binding sites [11,12]. Lectins 
represent interesting and attractive molecular recognition elements for the 
oriented immobilization of glycoproteins through sugar-lectin biospecific 
interactions [13–16]. In particular, Concanavalin A (ConA) is a homotetramer 
protein (molecular weight, 104 kDa for tetramer) that contains four specific sites 
with sugar recognition properties for supramolecular binding of polysaccharides, 
glycoproteins and glycolipids through D-glucose and D-mannose residues [17–
19]. It is important to remark that the binding of a glycoenzyme through its 
carbohydrate residues is not likely to affect neither its prosthetic site nor its 













are not involved in the catalytic activity of these enzymes, retaining most of their 
biological function even when their sugar chains are blocked [20,21]. 
Several works have reported the functionalization of CNTs with ConA 
through the use of different linkers attached to the nanostructures; however, to 
the best of our knowledge, the direct functionalization of CNTs with ConA has not 
been reported yet. Xue et al. [22] have proposed the attachment of ConA to multi-
walled carbon nanotubes (MWCNTs) non-covalently functionalized with 
poly(diallyl dimethylammonium chloride) by electrostatic interactions. Li et al. [23] 
have reported the use of MWCNTs modified with Pt nanoparticles and chitosan 
for further immobilization of Con A through electrostatic interactions. The non-
covalent functionalization of SWCNTs with n-dodecyl β-D-maltoside for the 
immobilization of ConA through the maltoside residues has been reported by Li 
et al. [24]. Papper et al. [25] have described the synthesis and 
electropolymerization of a pyrrolic ConA derivative onto a MWCNTs-modified 
electrode.  
In this work, we propose a new strategy to non-covalently functionalize 
MWCNTs with ConA in a direct way and to provide them of specific properties for 
the supramolecular immobilization of glycoenzymes. In the following sections we 
discuss the preparation, optimization and characterization of MWCNTs-ConA 
dispersion, and the analytical application of GCE modified with this dispersion for 
the preparation of monoenzymatic (GCE/MWCNTs-ConA/GOx) and bienzymatic 
(GCE/MWCNTs-ConA/HRP-GOx) glucose biosensors through the 
















2.1. Chemicals and solutions 
Multi-walled carbon nanotubes (MWCNTs, (30 ± 15) nm diameter, (1-5) 
µm length and purity higher than 95%), were supplied from Nanolab (USA). 
Concanavalin A (ConA) (Type VI, from Canavalia ensiformis), glucose oxidase 
(GOx) (Type X-S, from Aspergillus niger, EC 1.1.3.4, 157,500 units/g of solid), 
horseradish peroxidase (HRP) (Type I, 120 units/mg of solid), uric acid and 
hydroquinone were purchased from Sigma. β-D-(+)-glucose was obtained from 
Merck. Hydrogen peroxide (30% v/v aqueous solution), ascorbic acid, NaH2PO4 
and Na2HPO4 were supplied from Baker. Other chemicals were of analytical 
grade and used without further purification. The analyzed samples were nasal 
spray Alenys® (purchased from a local drugstore) and Standatrol SE serum 
(obtained from Wiener lab.) 
A 0.050 M phosphate buffer solution pH 7.40 was employed as supporting 
electrolyte. Ultrapure water (ρ = 18.2 MΩ cm) from a Millipore-MilliQ system was 
used for preparing all the solutions.  
 
2.2. Apparatus  
Sonication treatments were carried out with a VCX 130W ultrasonic 
processor (Sonics and Materials, Inc.) of 20 kHz frequency with a titanium alloy 
microtip (3 mm diameter). 
Scanning Electron Microscopy (SEM) images were obtained with a Field 
Emission Gun Scanning Electron Microscope (FE-SEM, Zeiss, ΣIGMA model) 
equipped with secondary and back-scattered electron detectors. The samples 
were obtained by casting glassy carbon disks with the MWCNTs dispersions 













Uv-vis absorption spectra were obtained with a Shimadzu UV-1700 
Pharma spectrophotometer using a quartz cuvette of 1 mm path length. 
Electrochemical experiments were carried out with a TEQ_04 potentiostat. 
Glassy carbon (GCE, CH Instruments, 3mm diameter) and modified-GCE were 
used as working electrodes. A platinum wire and Ag/AgCl, 3 M NaCl (BAS, Model 
RE-5B) were used as auxiliary and reference electrodes, respectively. All 
potentials are referred to this reference electrode. A magnetic stirrer under 
controlled speed provided the convective transport during the amperometric 
measurements.  
 
2.3. Preparation of MWCNTs-ConA dispersion 
The MWCNTs-ConA dispersion was prepared by mixing 1.5 mg of 
MWCNTs with 1.0 mL of 2.0 mg mL-1 ConA solution (prepared in water) followed 
by sonication with a sonicator probe for 5.0 min. The amplitude was 50% and the 
sample was kept in an ice-bath during this treatment (Figure 1A). For comparison, 
a dispersion of MWCNTs in water (MWCNTs-water) was prepared using the 
same conditions. 
 
2.4. Preparation of glassy carbon electrodes modified with MWCNTs-ConA 
dispersion (GCE/MWCNTs-ConA) 
GCE surfaces were polished with alumina slurries (1.0, 0.3 and 0.05 m) 
for 1 min each, rinsed thoroughly with deionized water, sonicated for 30 s in 
water, and finally dried under a N2 stream. GCE/MWCNTs-ConA was prepared 
by casting 10 µL of MWCNTs-ConA onto the glassy carbon surface, followed by 













the GCE was also modified with MWCNTs dispersed in water, followed by the 
addition of 10 µL of 2.0 mg mL-1 ConA solution (prepared in water), once the 
solvent was evaporated (GCE/MWCNTs/ConA). The resulting bioelectrodes 
were exhaustively rinsed with deionized water before using. 
 
2.5. Preparation of mono- and bienzymatic glucose biosensors  
Monoenzymatic glucose biosensor (GCE/MWCNTs-ConA/GOx): The 
immobilization of GOx was carried out by dropping 20 µL of a 5.0 mg mL-1 GOx 
solution (prepared in a 0.050 M phosphate buffer solution pH 7.40) onto 
GCE/MWCNTs-ConA for 5.0 min under conditions that avoiding the solvent 
evaporation (Figure 1B).  
Bienzymatic glucose biosensor (GCE/MWCNTs-ConA/HRP-GOx): 
This biosensor was prepared by dropping 20 µL of a solution containing 5.0 mg 
mL-1 GOx and 2.5 mg mL-1 HRP (in the same buffer) onto GCE/MWCNTs-ConA 
for 5.0 min under conditions that avoiding the solvent evaporation (Figure 1B). 
Both biosensors were exhaustively rinsed with 0.050 M phosphate buffer 





Amperometric experiments were performed in a stirred 0.050 M phosphate 
buffer solution pH 7.40 by applying 0.700 V as working potential in the case of 
GCE/MWCNTs-ConA/GOx biosensor, and -0.050 V in a 1.0 x 10-4 M 













in the case of GCE/MWCNTs-ConA/HRP-GOx. All experiments were conducted 
at room temperature.  
 
2.7. Determination of glucose in real samples 
A stock solution of nasal spray was prepared by dissolving the content of 
five doses of the spray in 5.0 mL of 0.050 M phosphate buffer solution pH 7.40. 
A 30 L-aliquot of this solution was directly transferred to the electrochemical cell 
containing 5.0 mL of a 0.050 M phosphate buffer solution pH 7.40, and the 
determination of glucose was performed by amperometry at 0.700 V using 
GCE/MWCNTs-ConA/GOx biosensor. Lyophilized serum was reconstituted with 
5.0 mL of ultrapure water by mixing up to total dissolution according to the 
instructions of supplier. A 10 L-aliquot of this solution was directly transferred to 
the electrochemical cell containing 5.0 mL of 1.0 x 10-4 M hydroquinone solution 
(prepared in a 0.050 M phosphate buffer solution pH 7.40), and the determination 
of glucose was performed by amperometry at -0.050 V using GCE/MWCNTs-
ConA/HRP-GOx biosensor. The quantification of glucose was accomplished by 




3. RESULTS AND DISCUSSION 
3.1. Characterization of MWCNTs-ConA dispersion 
 Figure 2A shows pictures of MWCNTs-dispersions prepared in water (a) 
and ConA solution (b). As can be seen, the MWCNTs-water dispersion presents 













interactions between the nanotubes walls. On the contrary, a large decrease of 
these aggregates is observed in the presence of the lectin as dispersing agent 
since the non-covalent functionalization of MWCNTs with ConA minimizes these 
interactions improving their compatibility in aqueous media. 
Figure 2B and C show SEM images obtained for glassy carbon disks 
modified with MWCNTs-water (B) and MWCNTs-ConA (C) dispersions. In the 
case of the water-dispersed MWCNTs, there is a large number of aggregates of 
MWCNTs as a consequence of their poor dispersion (see Fig 2A,a), at variance 
with the glassy carbon surface covered by MWCNTs dispersed in ConA where 
the MWCNTs are efficiently entrapped within the lectin net, decreasing, in this 
way,  the number of aggregates.  
Figure SI-1 displays UV-vis spectra for Con A solution before (a), and after 
sonication in the presence of MWCNTs followed by the separation of MWCNTs-
ConA by centrifugation at 12000 rpm for 15 min (b). The spectrum of native ConA 
shows an absorption band centered at 277 nm due to the absorption of the 
aromatic amino acids residues [26]. After sonication of MWCNTs with ConA and 
separation of MWCNTs-ConA by centrifugation, it was observed a slight red-shift 
in the wavelength of maximum absorption (279 nm), probably due to some 
degree of denaturation of the lectin by the effect of ultrasound energy and an 
obvious decrease in the maximum absorption. These results indicate in an 
indirect way, that ConA was bound to MWCNTs (in addition to the confirmation 
through the interaction with glycoenzymes discussed in the following sections). 
The interaction between MWCNTs and ConA could be stablished between the π-
system of nanotubes and the cavities of the protein rich in hydrophobic 













from the difference between the maximun absorbace of the polypeptide chains-
band for the ConA solution before and after the interaction with MWCNTs and 
separation of MWCNTs-Con A, was 0.72 mg per mg of MWCNTs. 
To evaluate if ConA retains its unique properties for the specific recognition 
of glycoproteins even after the sonication step during the preparation of the 
dispersion, we studied the interaction of GCW/MWCNTs-ConA with GOx as a 
model glycoenzyme. Figure 3A shows a cyclic voltammogram obtained in a 0.050 
M phosphate buffer solution pH 7.40 at 0.050 V s-1 for GCE/MWCNTs-
ConA/GOx. A well-defined quasi-reversible redox peaks-system, due to the 
reduction/oxidation of the prostetic group of the enzyme (FAD), is observed at -
0.437 V (anodic peak) and -0.507 V (cathodic peak), with a peak potential 
separation of 70 mV and a formal potential of -0.472 V. These values are in 
agreement with those reported in the literature [28–30]. No redox peaks system 
was observed when GOx was allowed to interact with GCE/MWCNTs (without 
ConA) (not shown). These results clearly indicate that the ConA that supports the 
carbon nanostructures allows the recognition of GOx even after the sonication 
treatment used to prepare the dispersion, and this intimate contact between lectin 
and enzyme, makes possible the direct electron transfer between the FAD center 
of the enzyme and the electrode surface. The linear relationship between the 
cathodic and anodic peaks currents and the scan rate in the range between 0.010 
and 0.100 V s-1 confirms that the reduction/oxidation of FAD/FADH2 is a surface-
controlled quasi-reversible process (inset in Figure 3A). The average surface 
concentration (Γ) of electroactive GOx present in GCE/MWCNTs-ConA/GOx was 














where v is the scan rate, n is the number of the electrons involved in the redox 
process, F is the Faraday constant, A is the effective area of the electrode, R is 
the gas constant, and T is the temperature. This average coverage was  2.33 
x10-11 molcm-2. As control, the average coverage obtained at 
GCE/MWCNTs/ConA/GOx was 1.07 x 10-11 mol cm-2, that is 2.2 times lower than 
the one obtained at GCE/MWCNTs-ConA/GOx, thus, confirming the increased 
glycoprotein loading when MWCNTs are dispersed in ConA. 
 Figure 3B displays cyclic voltammograms for GCE/MWCNTs-ConA/GOx 
in N2-satured 0.050 M phosphate buffer solution pH 7.40 containing 5.0 x10-4 M 
ferrocene methanol without (black curve, a) and with (red curve, b) 5.0 x10-2 M 
glucose. In the absence of glucose, a quasi-reversible peaks-system is observed 
due to the redox behavior of ferrocene methanol, while in the presence of glucose 
the anodic peak current largely increases and the cathodic one decreases, as 
expected for the biocatalytic activity of GOx. The surface coverage of bioactive 
GOx (Γ *GOx) present at the GCE/MWCNTs-ConA/GOx was calculated according 
to the Bourdillon method using the following equation [31]: 
 
where [FcMOH·+] and [Glu] are the concentrations of the oxidized mediator and 
substrate, respectively; kred = k1k2/(k-1 + k2), and icat, is the catalytic current 
determined at GCE/MWCNTs-ConA/GOx as the difference between the current 
obtained in the absence and presence of 5.0 x10-2 M glucose. The constant 
values used for the calculation were k2 = 780 s-1, k3 = (6.2 ± 0.5) x 10-6 M-1 s-1, 
and kred = 1.2 x104 M-1 s-1. Under our experimental conditions, ΓGOx was 4.2 x 10-













18% of the average coverage of electroactive GOx. These results clearly indicate 
that GCE/MWCNTs-ConA allows the specific recognition of the glycoenzyme 
retaining its biocatalytic activity and opening the doors for the development of 
glucose biosensors. 
 
3.2. Optimization of MWCNTs-ConA dispersion and construction of the 
glucose biosensors 
 The optimization of the experimental conditions for the preparation of 
MWCNTs-ConA dispersion (amount of MWCNTs, concentration of ConA and 
sonication time) was performed in two ways. In the first one, we evaluated the 
effectiveness of the dispersion through the amperometric response of H2O2 at 
0.700 V by using GCE/MWCNTs-ConA. In the second one, we evaluated the 
biorecognition properties of MWCNTs-ConA through the amperometric response 
of glucose at 0.700 V by using GCE/MWCNTs-ConA/GOx. The potential of 0.700 
V was selected from the evaluation of the voltammetric response obtained in the 
presence of 2.0 x 10-2 M glucose at GCE/MWCNTs-ConA/GOx (See Figure SI-
2). 
Figure 4 shows the effect of the amount of MWCNTs present in the 
MWCNTs-ConA dispersion on the sensitivity for H2O2 (A) and glucose (B), 
obtained from amperometric experiments performed at 0.700 V using GCE 
modified with MWCNTs-ConA dispersions prepared by sonication of different 
amounts of MWCNTs (0.5, 1.0, 1.5 and 2.0 mg) in 1.0 mL of 2.0 mg mL-1 ConA 
(prepared in water) for 5.0 min. Both sensitivities increase up to 1.5 mg of 
MWCNTs and level off or slightly decreases thereafter, suggesting that the 













1.5 mg of MWCNT was selected for preparing further MWCNTs-ConA 
dispersions. 
The concentration of dispersing agent is an important parameter that 
influences the efficiency of MWCNTs dispersions since it works as spacer 
between the nanotubes [32]. The effect of the concentration of ConA used to 
prepare the MWCNTs dispersions was evaluated in the range between 0 and 3.0 
mg mL-1 (Figure 4C-D). The sensitivities to H2O2 and glucose increase up to 2.0 
mg mL-1 and level off thereafter. Higher concentration of ConA produces a small 
decrease in the sensitivities which is attributed to the blockage of the electrode 
surface. According to these results, we selected 2.0 mg mL-1 ConA to obtain the 
most efficient carbon nanotubes dispersion with the best biorecognition 
conditions to immobilize the glycoenzyme GOx.  
The time of ultrasonic treatment during the preparation of the dispersion is 
another important parameter. The sonication time should be high enough to allow 
the separation of the nanotubes as a consequence of the intimate interaction 
between the lectin and nanotube walls, but not too high that completely denature 
the Con A. Figure 4 shows the sensitivities for H2O2 (E) and glucose (F) obtained 
using GCE modified with MWCNTs-ConA dispersions prepared using different 
sonication times (0, 1.0, 2.5, 5.0 and 7.5 min). A period of 5.0 min sonication was 
the best to obtain the highest sensitivity either in the case of hydrogen peroxide 
(A) or glucose (B). Longer times were not beneficial probably due to some change 
in the characteristics of the lectin that make the dispersion less efficient. 














The interaction time between GOx and GCE/MWCNTs-ConA and the 
concentration of GOx were also optimized through the amperometric response of 
glucose. Figure SI-3A shows the sensitivities for glucose obtained at 
GCE/MWCNTs-ConA/GOx biosensors prepared through the interaction of a 5.0 
mg mL-1 GOx solution with GCE/MWCNTs-ConA for different times (1.0, 2.0, 5.0 
and 30.0 min). As can be seen, just one minute is enough to reach the highest 
sensitivity, demonstrating the excellent biorecognition properties of the 
immobilizaed ConA. An incubation time of 5.0 min was selected as a compromise 
between the highest sensitivity and the best reproducibility. It is also interesting 
to remark that the sensitivity of the biosensor increased progressively with the 
concentration of the enzyme, reaching the highest value for a 5.0 mg mL-1 GOx 
solution (Figure SI-3B). 
 
3.3. Analytical performance of the glucose biosensors (GCE/MWCNTs-
ConA/GOx and GCE/MWCNTs-ConA/HRP-GOx) 
Figure 5 displays the amperometric response obtained under the optimal 
conditions at GCE/MWCNTs-ConA/GOx for successive additions of glucose in a 
stirred 0.050 M phosphate buffer solution pH 7.40 at 0.700 V (A), and the resulting 
calibration plot (B). A clearly defined and fast (5 seconds) response is obtained 
after the addition of micromolar levels of glucose, evidencing an efficient 
transduction of the biorecognition event by the bioanalytical platform. The 
calibration plot shows a linear range from 5.0 x 10-6 M to 1.2 x 10-3 M (r2=0.997), 
with a sensitivity of (2.22 ± 0.03) µA mM-1, and a limit of detection of 1.6 µM (taken 














The reproducibility obtained with five GCE/MWCNTs-ConA/GOx 
biosensors prepared with the same dispersion was 6.8%, while the reproducibility 
obtained with eleven GCE/MWCNTs-ConA/GOx biosensors prepared with 
eleven MWCNTs-ConA dispersions obtained in different days was 9.2%. The 
repeatability of GCE/MWCNTs-ConA/GOx, obtained from five consecutive 
glucose determinations, was 3.0%. The reproducibility and repeatability were 
calculated from the sensitivity to glucose obtained from amperometric 
experiments. The stability of the MWCNTs-ConA dispersion was evaluated from 
the sensitivity to glucose performed with GCE/MWCNTs-ConA/GOx biosensors 
prepared each testing day with a MWCNTs-ConA dispersion stored at 4 ºC. 
Negligible changes were obtained in the sensitivity to glucose during 33 days, 
with a loss of sensitivity of 20% after 44 days and 22% after the 65th day, 
demonstrating the high stability of MWCNTs-ConA dispersion. 
The selectivity of GCE/MWCNTs-ConA/GOx was evaluated in the 
presence of 2.5 x 10-4 M fructose, galactose, maltose and lactose, and no 
interference was observed in any case (not shown). The glucose content in a 
nasal spray, which contains glucose as excipient, was evaluated as real 
application for GCE/MWCNTs-ConA/GOx biosensor. The concentration of 
glucose, obtained from 6 determinations, was (2.78 ± 0.09) mg per dose, showing 
an excellent agreement with the value reported in the pharmaceutical product 
(2.75 mg of glucose per dose), demonstrating the usefulness of GCE/MWCNTs-
ConA/GOx for the quantification of glucose in this medicine sample. 
However, even when this biosensor present competitive analytical 
characteristics, it has the inconvenience of the interference of uric acid (UA) and 













of 2.5 x 10-4 M glucose, there is an interference of 23 % for 5.0 x 10-6 M AA and 
76 % for 2.5 x 10-5 M UA. The incorporation of a layer of 1.0% Nafion solution 
(prepared in 0.050 M phosphate buffer pH 7.40) at GCE/MWCNTs-ConA/GOx 
decreased the interferences to 4.5% and 22% for AA and UA, respectively. 
To overcome this problem, we investigated the co-immobilization of two 
glycoenzymes, HRP and GOx at the surface of GCE/MWCNTs-ConA to build a 
glucose bienzymatic platform (GCE/MWCNTs-ConA/HRP-GOx). The analytical 
signal for GCE/MWCNTs-ConA/HRP-GOx was obtained from amperometric 
experiments at -0.050 V by using 1.0 x 10-4 M hydroquinone as redox mediator. 
The working potential was selected from the voltammetric response obtained at 
GCE/MWCNTs-ConA/HRP-GOx in the absence and presence of 2.0 x 10-2M 
glucose in a solution containing 1.0 x 10-4 M hydroquinone (See Figure SI-4). 
GOx/HRP ratio used to prepare GCE/MWCNTs-ConA/HRP-GOx is a 
critical aspect for the analytical performance of the biosensor. Figure 6A shows 
the variation of the sensitivity to glucose obtained for bienzymatic biosensors 
prepared with a constant concentration of HRP (2.5 mg mL-1) and different 
concentrations of GOx, while Figure 6B displays the effect of GOx/HRP ratio for 
a constant GOx concentration (5.0 mg mL-1) and different concentrations of HRP. 
The maximum sensitivity was obtained when using 5.0 mg mL-1 GOx and 2.5 mg 
mL-1 HRP, therefore, these enzyme concentrations were selected for the 
bienzymatic biosensor preparation.  
Figure 7A shows the amperometric response obtained at optimized 
GCE/MWCNTs-ConA/HRP-GOx at - 0.050 V for successive additions of glucose 
in a stirred 1.0 x 10-4 M hydroquinone solution (prepared in a 0.050 M phosphate 













curve. A fast and even better defined amperometric response is obtained after 
the successive additions of glucose (compared to the monoenzymatic biosensor). 
The bienzymatic biosensor presents a linear range between 2.0 x 10-6 M and 4.1 
x 10-4 M (r2=0.9998), covering two orders of magnitude, with a sensitivity of (11.5 
± 0.4) µA mM-1, which is 5.2 times higher than that obtained at GCE/MWCNTs-
ConA/GOx biosensor ((2.22 ± 0.03) µA mM-1). Moreover, the limit of detection 
(taken as indicated before) was estimated to be 0.31 µM, that is almost one order 
of magnitude lower than that obtained with the monoenzymatic biosensor (1.6 
µM). The limit of detection obtained with our bienzymatic biosensor was lower or 
comparable to the ones of most of the enzymatic glucose biosensors based on 
the H2O2 reduction reported in the last years (Table 1). Therefore, 
GCE/MWCNTs-ConA/HRP-GOx allow to work at lower potentials, with increased 
sensitivity and selectivity,  
The sensitivities obtained with five different GCE/MWCNTs-ConA/HRP-
GOx biosensors showed a RSD value of 5.4%, indicating an excellent 
reproducibility in the whole preparation process of the bioanalytical platform. In 
addition to the significant increment in sensitivity, the bienzymatic biosensor 
presents the great advantage of using a low working potential for the 
amperometric detection of glucose, allowing in this way the elimination of the 
interference produced by ascorbic and uric acids, thus improving the selectivity 
of the biosensor (Figure SI-5). 
To demonstrate the usefulness of the proposed bienzymatic biosensor in 
a complex matrix, we quantify glucose in blood human serum samples. The 
average concentration of glucose obtained from 4 determinations was (0.84 ± 













laboratory (0.87 g/L). These results demonstrate once more the advantages of 
the bienzymatic biosensor that allows to work a onsiderably lower potentials, 
largely decreasing the interference of easily oxidizable compounds, and allowing, 
in this way, the use of biosensor for the quantification of glucose in complex 
samples like blood human serum without any pretreatment. 
 
4. CONCLUSIONS 
We demonstrate here that, at variance with previous reports, MWCNTs 
can be non-covalently functionalized with ConA in a direct way just by sonicating 
them in the presence of ConA. The resulting MWCNTs-ConA dispersion was 
successfully used as building block to develop biosensors through the 
supramolecular site-specific recognition of glycobiomolecules.  In this case, as 
proof-of-concept, we developed glucose biosensors based on the immobilization 
of two glycoproteins, GOx and HRP, to prepare either mono- and bienzymatic 
biosensors. The advantages of the cascade reactions at GCE/MWCNTs-
ConA/HRP-GOx between glucose/GOx and hydrogen peroxide/HRP mediated 
by hydroquinone was clearly demonstrated through the important increase in the 
sensitivity to glucose, the significant improvement in the selectivity and the 
successful application in complex matrices like human blood serum.   
In summary, MWCNTs-ConA represents a very attractive platform for the 
development of different biosensing strategies either by specific-anchoring of a 
selected glycobiomolecule able to be used as biorecognition element, by direct 
quantification of relevant glycoproteins or bacteria, or by using the MWCNTs-
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LEGENDS OF THE FIGURES 
 
Figure 1: Schematic representation of the steps involved in the preparation of 
the glucose biosensors. 
 
Figure 2: (A) Pictures of MWCNTs dispersions prepared in water (a) and ConA 
solution (b), obtained by ultrasonication for 5.0 min. SEM micrograph of glassy 
carbon disk modified with dispersions of MWCNTs-water (B) and MWCNTs-
ConA (C). Magnification: 3810X. The insets corresponds to SEM micrographs at 
higher magnification (22870X). 
 
Figure 3: 
(A) Cyclic voltammogram obtained at GCE/MWCNTs-ConA in a solution of N2-
satured 0.050 M phosphate buffer solution pH 7.40. Scan rate: 0.100 Vs-1. Inset: 
Dependence of peak currents on the scan rates. (B) Cyclic voltammograms for 
5.0 x 10-4 M ferrocene methanol at GCE/MWCNTs-ConA/GOx in a N2-satured 
0.050 M phosphate buffer solution pH 7.40 without (black curve) and with 0.050 
M glucose (red curve). Scan rate: 0.005 Vs-1. 
 
Figure 4: Variation of the sensitivity obtained from amperometric experiments 
performed at GCE/MWCNTs-ConA for H2O2 (A, C, E), and at GCE/MWCNTs-
ConA/GOx for glucose (B, D, F) as a function of the amount of MWCNTs (A, B), 
ConA concentration (C, D) and sonication time (E, F) used to prepare MWCNTs-














Figure 5: (A) Amperometric recording for successive additions of glucose at 
GCE/MWCNTs-ConA/GOx: (a) 5.0 x 10-6 M, (b) 1.0 x 10-5 M, (c) 5.0 x 10-5 M, and 
(e) 1.0 x 10-4 M. (B) Calibration plot obtained from the amperometric recording 
shown in Figure 5A. Supporting electrolyte: 0.050 M phosphate buffer solution 
pH 7.40. Working potential: 0.700 V.  
 
Figure 6: Variation of the glucose sensitivity as a function of the concentration of 
(A) HRP and (B) GOx used to prepare GCE/MWCNTs-ConA/HRP-GOx. 
Supporting electrolyte: 0.050 M phosphate buffer solution pH 7.40, containing 1.0 
x 10-4 M hydroquinone. Working potential: -0.050 V. 
 
Figure 7: (A) Amperometric recording for successive additions of glucose at 
GCE/MWCNTs-ConA/HRP-GOx: (a) 2.0 x 10-6 M, (b) 5.0 x 10-6 M, (c) 1.0 x 10-5 
M, (d) 5.0 x 10-5 M, and (e) 1.0 x 10-4 M. (B) Calibration plot obtained from the 
amperometric recording shown in Figure 7A. Supporting electrolyte: 0.050 M 
phosphate buffer solution pH 7.40, containing 1.0 x 10-4 M hydroquinone. 
Working potential: -0.050 V. 
 
 
















FIGURE 2- Rivas ET AL. 
 
20 µL of 5.0 mg mL-1 GOx for 5.0 min
1.5 mg MWCNTs 1.0 mL 2.0 mg mL-1 Con A 
(in water)
Sonication with sonicator probe












































FIGURE 4- Rivas ET AL. 
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FIGURE 5- Rivas ET AL. 
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FIGURE 7- Rivas ET AL. 
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Table 1 – RIVAS ET AL. 
 
 
ELECTROCHEMICAL PLATFORMS FOR GLUCOSE BIOSENSING 




















































(5 – 1200) µM  
(2 – 410) µM 
(2.22 ± 0.03) µA mM-1 




GCE: glassy carbon electrode; MWCNTs: multi-walled carbon nanotubes; Cyt c: cytochrome c; GOx: glucose oxidase; Naf: 
nafion; PEG: polyethylene glycol; IL: ionic liquid; rGO: reduced graphene oxide; pTB: poly(toluidine blue); HRP: horseradish 
peroxidase; SPCE: screen-printed carbon electrode; ERGO: electrochemically reduced graphene oxide; IL-CHO: aldehyde 
functionalized ionic liquid; AuE: gold electrode; PEDOT: poly(3,4-ethylenedioxythiophene); PSS: poly(styrene sulfonate); CS: 
chitosan; NGr: nitrogen doped graphene; AuNFs: gold nanoflowers; GS: graphene sheets; AuNRs: gold nanorods; GA:  
glutaraldehyde; TCNFs: titanium carbinde-carbon nanofibers; KB: Ketjen Black; HNF: hollow nanofibers; CaTiO3NPs: 
perovskite-type calcium titanate nanoparticles; NiONPs: nickel oxide nanoparticles. 
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